A detailed history of Catalina Capital Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Catalina Capital Group, LLC holds 11,013 shares of PFE stock, worth $311,667. This represents 0.11% of its overall portfolio holdings.

Number of Shares
11,013
Previous 7,886 39.65%
Holding current value
$311,667
Previous $221 Million 44.45%
% of portfolio
0.11%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$27.7 - $31.39 $86,617 - $98,156
3,127 Added 39.65%
11,013 $319 Million
Q2 2024

Jul 24, 2024

BUY
$25.26 - $29.6 $199,200 - $233,425
7,886 New
7,886 $221 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $159B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Catalina Capital Group, LLC Portfolio

Follow Catalina Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalina Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalina Capital Group, LLC with notifications on news.